Premium
Cyproterone acetate in advanced male breast cancer
Author(s) -
Lopez Massimo,
Barduagni Aldo
Publication year - 1982
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19820101)49:1<9::aid-cncr2820490103>3.0.co;2-#
Subject(s) - cyproterone acetate , medicine , cyproterone , male breast cancer , breast cancer , antiandrogen , cancer , gynecology , oncology , urology , prostate cancer , androgen , hormone
Three male patients of 55, 63 and 71 years of age, with metastatic breast cancer, were treated with cyproterone acetate. Two patients showed complete remission, one lasting 21 months, another 51+ months and a third achieved partial remission lasting 9 months. These results suggest that cyproterone acetate may be useful in the treatment of advanced male breast cancer.